Assessment of awareness of uterine fibroid among women in Kerala, India

Nissy P Jacob


Uterine fibroid is a common pelvic tumor seen in women of reproductive age causing complications and affecting the quality of life of women. The goal of this study was to assess the awareness of uterine fibroid among women in Kerala. An online based study was carried out among women (n=417) in Kerala. The questionnaire was divided into 2 parts, part 1 about sociodemographic information, and the next part consisted of 21 questions which evaluated the knowledge of women towards uterine fibroid. The contact numbers or mail ID of women of different age groups were collected from certain women’s social groups. The prepared questionnaire has been sent to women through social medias such as WhatsApp, Facebook, Gmail and the responses were collected. This study concluded that, while women are aware of uterine fibroid, there are many misconceptions about uterine fibroid among women, and thus awareness must be spread about it. Various measures such as educational programs and camps must be conducted in rural areas to improve the awareness of uterine fibroid among women which help in early management and thereby preventing the complications of the disease.


Baird, D.D., Dunson, D.B., Hill, M.C., Cousins, D., “Schectman JM. High incidence of uterine leiomyoma in black and white women: ultrasound evidence,” Am J Obstet Gynecol. 188: 100-107, 2003.

Laughlin, S.K., Stewart, E.A., “Uterine leiomyomas: individualizing the approach to a heterogeneous condition,” Obstet Gynecol. 117: 396-403, 2011.

Parker, W.H., “Uterine myomas: management,” Fertil Steril. 88: 255-271, 2007.

Zimmermann, A., Bernuit, D., Gerlinger, C., Schaefers, M., Geppert, K., “Prevalence, symptoms a d management of uterine fibroids: an international internet-based survey of 21, 746 women,” Biomed Central Womens Health. 12: 6, 2012.

Stewart, E.A., “Clinical practice. Uterine fibroids,” N Eng J Med. 372: 1646-1655, 2015.

Downes, E., Sikirica, V., Gilbert, E.J., et al., “The burden of uterine fibroids in five European countries,” Eur J Obstet Gynecol Reprod Biol. 152: 96-102, 2010.

Kjerulff, K.H., Langenberg, P., Seidman, J.D., Stolley, P.D., Guzinski, G.M., “Uterine leiomyomas: racial differences in severity, symptoms and age at diagnosis,” J Reprod Med. 41: 483-490, 1996.

Ross, R.K., Pike, M.C., Vessey, M.P., Bull, D., Yeates, D., Casagrande, J.T., “Risk factors for uterine fibroids: reduced risk associated with oral contraceptives [published erratum in BMJ 1986; 293:1027],” Br Med J. 293: 359-362, 1986.

Paraziini, F., La, V.C., Negri, E., Cecchetti, G., Fedele, L., “Epidemiologic characteristics of women with uterine fibroids: a case-control study,” Obstet Gynecol. 72: 853-857, 1988.

Marshall, L.M., Spiegelman, D., Goldman, M.B., et al., “A prospective study of reproductive factors and oral contraceptive use in relation to the risk of uterine leiomyomata,” Fertil Steril. 70: 432-439, 1998.

Parazzini, F., Negri, E., La, V.C., et al., “Uterine myomas and smoking: results from an Italian study,” J Reprod Med. 41: 316-320, 1996.

Chiaffarino, F., Parazzini, F., La, V.C., Marsico, S., Surace, M., Ricci, E., “Use of oral contraceptives and uterine fibroids: results from a case-control study,” Br J Obstet Gynecol. 106: 857-860, 1999.

Stewart, E.A., Nowark, R.A., “New concepts in the treatment of uterine leiomyomas,” Obstet Gynecol. 92: 624-627, 1998.

Chiaffarino, F., Parazzini, F., La ,V.C., Chatenoud, L., Di, C.E., Marsico, S., “Diet and uterine myomas,” Obstet Gynecol. 94: 395-398, 1999.

Marret, H., Fritel, X., Ouldamer, L., et al., “N Therapeutic management of uterine fibroid tumors: updated French guidelines,” Eur J Obstet Gynecol Reprod Biol. 165: 156-64, 2012.

Stewart, E.A., Shuster, L.T., Rocca, W.A., “Reassessing hysterectomy,” Minn Med. 95: 36-39, 2012.

Lukes, A.S., Moore, K.A., Muse, K.N., et al., “Tranexamic acid treatment for heavy menstrual bleeding: a randomized controlled trial,” Obstet Gynecol. 116: 865-875, 2010.

Gupta, J.K., Sinha, A., Lumsden, M.A., Hickey, M., “Uterine artery embolization for symptomatic uterine fibroids,” Cochrane Database Syst Rev. (5): CD005073, 2012.

Spies, J.B., Coyne, K., Guaou, G.N., et al., “The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata,” Obstet Gynecol. 99: 290-300, 2002.

Karin, S.C., Mary, K.M., Linda, D.B., et al., “Further Validation of the Uterine Fibroid Symptom and Quality-of-Life Questionnaire,” Value Health, 1(15): 135-142, 2012.

Gale, H., Karin, S.C., Christine, L.T., “The responsiveness of the uterine fibroid symptom and health-related quality of life questionnaire (UFS-QOL),” BioMed Central. 6: 99, 2008.

Sarojini, K., Brundha, M.P., “Awareness on uterine fibroids among menopausal women-A survey,” Drug Invent Today. 13(6), 2020.

Preethi, K., Dhanraj, G., Brundha, P., “Awareness about fibroid among Indian women,” Drug Invent Today. 13(4): 507-510, 2020.

Aamir, T.K., Manjeet. S., Janesh, K.G., “Uterine fibroids:current perspectives. Int J Womens Health,” 6: 95-114, 2014.

Ertunc, D., Uzun, R., Tok, E.C., Doruk, A., Dilek, S., “The effect of myoma uteri and myomectomy on sexual function,” J Sex Med. 6(4): 1032-1038, 2009.

Marshall, L.M., Spiegelman, D., Manson, J.E., et al., “Risk of uterine leiomyomata among premenopausal women in relation to body size and cigarette smoking,” Epidemiol. 9(5): 511-517, 1998.

Wirth, M.M., Meier, E.A., Fredrickson, B.L., Schultheiss, O.C., “Relationship between salivary cortisol and progesterone levels in humans,” Biol Psychol. 74(1): 104–107, 2007.

Navaneetha, K.S., Vanaja, K., Ajay, C., et al., “Prevalence of risk factors for uterine fibroids at tertiary care teaching hospital: A cross-sectional study,” J Young Pharm. 12(1):86-89, 2020.

Rita, O.S., Mariano, T.V.G., Rodrigo, D.A.C., et al., “Uterine fibroid symptom-Quality of life questionnaire translation and validation into Brazilian Portugese,” Rev Bras Ginecol Obstet. 38(10): 16-25, 2016.

Atombosoba, A.E., Lucky, O.L., Chukwuemeka, A.I., et al., “Review of the clinical presentation of uterine fibroid and the effect of therapeutic intervention on fertility,” Am J Clin Med Res. 3(1): 9-13, 2015.

Katz, V.L., Dotters, D.J., Droegemueller, W., “Complications of uterine leiomyomas in pregnancy,” Obstet Gynecol. 73: 593-596, 1989.

Benson, C.B., Chow, J.S., Changlee, W., et al., “Outcomes of pregnancies in women with uterine leiomyomas identified by sonography in the first trimester,” J Clin Ultrasound. 29: 261-264, 2001.

Wallach, E.E., Vu, K.K., “Myomata uteri and infertility,” Obstet Gynecol Clin N Am. 22: 791-799, 1955.

Banu, N.S., Manyonda, I.T., “Myometrial tumours,” Curr Obstet Gynecol. 14(5): 327-336, 2004.

Emuveyan, E.E., Ifenne, I., Ohaju, O.J.O., “A randomized controlled study of Goserelin as adjunctive therapy prior to surgery in the management of uterine fibroid,” Trop J Obstet Gynecol. 22(2): 120-124, 2005.

Lizat, K.S., Serik, S.I., Ainur, S.T., et al., “Assessing the quality of life of patients with symptomatic uterine fibroid,” Syst Rev Pharm. 11(12): 42-49, 2020.

Mohanambal, M.M., Wills, G.S., Vijaya, P.L., “Clinical presentation and prevalence of uterine fibroids: a 3-year study in 3 decade rural South Indian women,” Int J Reprod Contracept Obstet Gynecol. 6(12): 5596-5601, 2017.



  • There are currently no refbacks.

International Journal of Public Health Science (IJPHS)
p-ISSN: 2252-8806, e-ISSN: 2620-4126

View IJPHS Stats

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.